WILMINGTON, Del., July 28, 2015 /PRNewswire/ --

Second Quarter Highlights

  • Delivered second-quarter operating earnings per share of $1.18 versus $1.17 in prior year. Performance Chemicals operating earnings were down $0.11 per share from prior year. GAAP earnings per share were $1.03 versus $1.15 in prior year.
  • Segment pre-tax operating earnings of $1,586 million included about $210 million, or $0.17 per share, of negative impact from currency. Excluding the impact of currency, operating EPS would have increased about 15 percent versus prior year.
  • Operating margins improved in 5 of the 6 ongoing operating segments which comprise the next generation DuPont including Performance Materials, Electronics & Communications, Agriculture, Nutrition & Health, and Safety & Protection. Margin improvement was primarily driven by increased productivity.
  • Cost reductions from operational redesign contributed $0.10 per share to second-quarter operating earnings; on track to deliver approximately $0.40 per share in savings in 2015.
  • On a continuing operations basis, DuPont expects full-year 2015 operating earnings to be about $3.10 per share, excluding $0.80 per share in previously anticipated full year earnings from Performance Chemicals. Estimated negative currency impact expected to be approximately $0.60 per share. Prior-year operating earnings were $3.36 per share on a comparable basis.

DuPont (NYSE: DD), a science company that brings world-class, innovative products, materials, and services to the global marketplace, today announced second quarter 2015 operating earnings of $1.18 per share compared to $1.17 per share in the prior year.  GAAP1 earnings were $1.03 per share, compared to $1.15 per share in the prior year.

Second quarter sales were $8.6 billion, down 11 percent versus prior year due to negative impacts from currency (5 percent), portfolio changes (2 percent), volume (2 percent) and local price and product mix (2 percent).  Segment pre-tax operating earnings of $1,586 million included about $210 million, or $0.17 per share, of negative impact from currency.  Operating earnings included $0.09 per share of benefit related to exchange gains and taxes, attributable to prior periods. Performance Chemicals segment operating earnings were $113 million, or $0.10 per share, a 55 percent reduction versus prior year. 

DuPont's board of directors approved a third quarter dividend of 38 cents per share, the 444th consecutive quarterly dividend since the company's first dividend in the fourth quarter of 1904. The third quarter dividend of 38 cents per share of common stock is payable on Sept. 11, 2015, to stockholders of record at the close of business on Aug. 14, 2015. Regular quarterly dividends of $1.125 per share on the $4.50 series preferred stock and $0.875 cents per share on the $3.50 series preferred stock also were declared, both payable on Oct. 23, 2015, to stockholders of record as of Oct. 9, 2015.

The separation of Chemours was completed on July 1, 2015. In the first quarter 2015, DuPont announced its intention to buy back shares using the approximately $4 billion of distribution proceeds received from Chemours. In connection with the completion of the spin, DuPont's board has authorized the company to purchase and retire $2 billion of common stock by Dec. 31, 2015 with the remainder to be purchased and retired by Dec. 31, 2016. The company expects to use an accelerated share repurchase plan in connection with the $2 billion buyback by year end.

"We continued to improve margins across most of our ongoing businesses through our constant focus on productivity, even as we address industrywide challenges in agriculture and ongoing currency headwinds," said Ellen Kullman, DuPont Chair and CEO.  "With the separation of our Performance Chemicals segment now complete, the next generation DuPont is leveraging our innovation platform to drive greater growth and value, with a continued emphasis on cost productivity, actively managing our portfolio, and the disciplined return of capital."

Global Consolidated Net Sales – 2nd Quarter

Three Months Ended










June 30, 2015

Percent Change Due to:






Local Price and




Portfolio /


$

% Change

Product Mix

Currency

Volume

Other














(Dollars in millions)












     U.S. & Canada

$    4,247

(8)

(2)

(1)

(3)

(2)

     EMEA *

1,732

(18)

-

(17)

2

(3)

     Asia Pacific 

1,883

(10)

(2)

(2)

(3)

(3)

     Latin America

733

(18)

-

(9)

(7)

(2)














Total Consolidated Sales

$    8,595

(11)

(2)

(5)

(2)

(2)














*  Europe, Middle East & Africa










Segment Sales – 2nd Quarter

Three Months Ended










June 30, 2015

Percent Change Due to:






Local Price and




Portfolio /


$

% Change

Product Mix

Currency

Volume

Other

(Dollars in millions)












Agriculture

$    3,218

(11)

1

(5)

(6)

(1)

Electronics & Communications

534

(13)

(4)

(2)

(7)

-

Industrial Biosciences

288

(9)

(3)

(8)

2

-

Nutrition & Health

826

(11)

(1)

(9)

-

(1)

Performance Chemicals

1,502

(11)

(6)

(4)

-

(1)

Performance Materials

1,365

(14)

(4)

(7)

3

(6)

Safety & Protection

925

(10)

-

(5)

-

(5)

Other

2










Total segment sales

8,660

(11)

(2)

(5)

(2)

(2)

Elimination of transfers

(65)










Consolidated net sales

$    8,595
























Operating Earnings – 2nd Quarter





















Change vs. 2014

(Dollars in millions)

2Q15

2Q14

$

%

Agriculture

$        778

$        836

$         (58)

-7%

Electronics & Communications

93

89

4

4%

Industrial Biosciences

50

59

(9)

-15%

Nutrition & Health

103

105

(2)

-2%

Performance Chemicals

113

251

(138)

-55%

Performance Materials

311

303

8

3%

Safety & Protection

195

209

(14)

-7%

Other

(57)

(82)

25

30%

Total segment operating earnings (1) 

1,586

1,770

(184)

-10%









Exchange gains (losses) (1), (2)

26

(51)

77

nm

Corporate expenses (1) 

(164)

(186)

22

-12%

Interest expense (1) 

(107)

(94)

(13)

14%

Operating earnings before income taxes 

1,341

1,439

(98)

-7%

Provision for income taxes on operating earnings 

(261)

(350)

89


Less: Net income attributable to noncontrolling interests 

5

4

1


Operating earnings

$      1,075

$      1,085

$         (10)

-1%









Operating earnings per share 

$        1.18

$       1.17

$        0.01

1%



























(1) See Schedules B and C for listing of significant items and their impact by segment.











(2) See Schedule D for additional information on exchange gains and losses.




The following is a summary of business results for each of the company's reportable segments comparing second quarter with the prior year, unless otherwise noted.

Agriculture – Operating earnings of $778 million decreased $58 million, or 7 percent, as improved productivity and increases in price from new products were more than offset by lower volumes and an $84 million negative currency impact.  Decreased volumes are due to reduced soybean sales, lower crop protection volumes and reductions in global corn planted area.  Excluding the impact of currency, operating earnings would have increased by about 3 percent.

Electronics & Communications – Operating earnings of $93 million increased $4 million, or 4 percent, as productivity gains more than offset volume decreases and a $3 million negative impact from currency. Volume growth in Tedlar® film in photovoltaics and consumer electronics was more than offset by competitive pressures impacting Solamet® paste. Excluding the impact of currency, operating earnings would have increased by about 8 percent.

Industrial Biosciences – Operating earnings of $50 million decreased $9 million, or 15 percent, as increased demand for bioactives was more than offset by lower pricing and a $6 million negative impact of currency. Increased enzyme demand, principally in animal nutrition, health and personal care, and food markets, was offset by lower biomaterial sales. Excluding the impact of currency, operating earnings would have been about 5 percent lower than prior year.

Nutrition & Health – Operating earnings of $103 million decreased $2 million, or 2 percent, as productivity gains were more than offset by a $12 million negative impact of currency. Volume growth in probiotics, texturants, cultures, and ingredient systems were offset by a decline in specialty proteins.  Excluding the impact of currency, operating earnings would have increased by about 10 percent.

Performance Chemicals – Operating earnings of $113 million decreased $138 million, or 55 percent, driven primarily by lower prices for titanium dioxide, and $43 million from the negative impact of currency. Excluding the impact of currency, operating earnings would have declined by about 38 percent.

Performance Materials – Operating earnings of $311 million increased $8 million, or 3 percent, driven by broad based improved product mix, productivity and volume growth for ethylene as prior year ethylene sales were constrained due to the scheduled outage at the Orange, Texas ethylene unit. This was offset by $42 million of negative impact of currency, the portfolio change from the sale of Glass Laminating Solutions/Vinyls, and a negative impact from an unplanned ethylene outage.  Excluding the impact of currency, operating earnings would have increased by about 17 percent.

Safety & Protection – Operating earnings of $195 million decreased $14 million, or 7 percent, as productivity improvements and volume growth in medical packaging and protective garments were more than offset by $20 million of negative currency impact, the portfolio impact of the Sontara® divestiture, and lower demand, particularly from the oil & gas industry, for Nomex® thermal resistant fiber and Sustainable Solutions offerings.  Excluding the impact of currency, operating earnings would have increased by about 3 percent.

Outlook

Consistent with continuing weakness in global agricultural markets, the company is reducing expectations for the year in its Agriculture segment due to weaker demand in global crop protection markets, reduced expectations for corn area in Latin America, and lower than expected soybean volumes in North America. The company continues to anticipate that the operational redesign will deliver savings of approximately $0.40 per share in 2015.  As a result, the company expects operating earnings per share for 2015 to be about $3.10 per share for the full year, excluding $0.80 per share of anticipated full-year earnings from the Performance Chemicals segment.  This represents a $0.10 per share reduction from the prior outlook of $4.00 per share, which included the Performance Chemicals segment.

DuPont will hold a conference call and webcast on Tuesday, July 28, 2015, at 9:00 AM EDT to discuss this news release.  The webcast and additional presentation materials can be accessed by visiting the company's investor website (Events & Presentations) at www.investors.dupont.com.  A replay of the conference call webcast will be available for 90 days by calling 1-630-652-3042, Passcode 38251527#.  For additional information see the investor center at http://www.dupont.com.

Use of Non-GAAP Measures

Management believes that certain non-GAAP measurements are meaningful to investors because they provide insight with respect to ongoing operating results of the company.  Such measurements are not recognized in accordance with GAAP and should not be viewed as an alternative to GAAP measures of performance.  Reconciliations of non-GAAP measures to GAAP are provided in schedules A, C and D.

About DuPont

DuPont (NYSE: DD) has been bringing world-class science and engineering to the global marketplace in the form of innovative products, materials, and services since 1802.  The company believes that by collaborating with customers, governments, NGOs, and thought leaders we can help find solutions to such global challenges as providing enough healthy food for people everywhere, decreasing dependence on fossil fuels, and protecting life and the environment.  For additional information about DuPont and its commitment to inclusive innovation, please visit http://www.dupont.com.

Forward Looking Statements: This document contains forward-looking statements which may be identified by their use of words like "plans," "expects," "will," "believes," "intends," "estimates," "anticipates" or other words of similar meaning. All statements that address expectations or projections about the future, including statements about the company's strategy for growth, product development, regulatory approval, market position, anticipated benefits of recent acquisitions, timing of anticipated benefits from restructuring actions, outcome of contingencies, such as litigation and environmental matters, expenditures and financial results, are forward looking statements. Forward-looking statements are not guarantees of future performance and are based on certain assumptions and expectations of future events which may not be realized. Forward-looking statements also involve risks and uncertainties, many of which are beyond the company's control. Some of the important factors that could cause the company's actual results to differ materially from those projected in any such forward-looking statements are: fluctuations in energy and raw material prices; failure to develop and market new products and optimally manage product life cycles; ability to respond to market acceptance, rules, regulations and policies affecting products based on biotechnology; significant litigation and environmental matters; failure to appropriately manage process safety and product stewardship issues; changes in laws and regulations or political conditions; global economic and capital markets conditions, such as inflation, interest and currency exchange rates; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war, weather events and natural disasters; ability to protect and enforce the company's intellectual property rights; successful integration of acquired businesses and separation of underperforming or non-strategic assets or businesses, including timely realization of the expected benefits from the separation of Performance Chemicals. The company undertakes no duty to update any forward-looking statements as a result of future developments or new information.


E.I. du Pont de Nemours and Company
Consolidated Income Statements
(Dollars in millions, except per share amounts)








SCHEDULE A







Three Months Ended

June 30,

Six Months Ended

June 30,

2015

2014

2015

2014

Net sales

$

8,595

$

9,706

$

17,767

$

19,834

Other income, net (1)

283

408

481

425

Total

8,878

10,114

18,248

20,259








Cost of goods sold

5,280

5,999

10,833

11,999

Other operating charges (1)

349

300

632

586

Selling, general and administrative expenses

1,371

1,473

2,683

2,909

Research and development expense

515

545

1,014

1,063

Interest expense (1)

127

94

211

197

Employee separation / asset related charges, net (1)

61

263

99

263

Total

7,703

8,674

15,472

17,017








Income before income taxes

1,175

1,440

2,776

3,242

Provision for income taxes (1)

230

366

796

723

Net income

945

1,074

1,980

2,519








Less:  Net income attributable to noncontrolling interests

5

4

9

10








Net income attributable to DuPont

$

940

$

1,070

$

1,971

$

2,509








Basic earnings per share of common stock

$

1.04

$

1.16

$

2.17

$

2.72








Diluted earnings per share of common stock

$

1.03

$

1.15

$

2.15

$

2.70








Dividends per share of common stock

$

0.49

$

0.45

$

0.96

$

0.90








Average number of shares outstanding used in earnings per share (EPS) calculation:






  Basic

905,761,000

918,684,000

906,296,000

921,058,000

  Diluted

911,681,000

925,587,000

912,748,000

928,145,000








 

Reconciliation of Non-GAAP Measures










Summary of Earnings Comparison











Three Months Ended

June 30,

Six Months Ended

June 30,

2015

2014

% Change

2015

2014

% Change

Net income (GAAP)

$

945

$

1,074

(12)%

$

1,980

$

2,519

(21)%

Less: Significant items (benefit) charge, after-tax, included in net income (per

Schedule B)

(85)

8


(211)

(4)

Non-operating pension/OPEB costs, after-tax, included in net income (2)

(50)

(23)


(121)

(44)

Net income attributable to noncontrolling interest

5

4


9

10

Operating earnings (Non-GAAP)

$

1,075

$

1,085

(1)%

$

2,303

$

2,557

(10)%












EPS attributable to DuPont (GAAP)

$

1.03

$

1.15

(10)%

$

2.15

$

2.70

(20)%

Less: Significant items (benefit) charge included in EPS (per Schedule B)

(0.09)

0.01


(0.23)

—

Non-operating pension/OPEB costs included in EPS (2)

(0.06)

(0.03)


(0.14)

(0.05)

Operating EPS (Non-GAAP)

$

1.18

$

1.17

1%

$

2.52

$

2.75

(8)%












 

E.I. du Pont de Nemours and Company
Condensed Consolidated Balance Sheets
(Dollars in millions, except per share amounts)



SCHEDULE A (continued)



June 30,

2015

December 31,

2014

Assets



Current assets



Cash and cash equivalents

$

4,746

$

6,910

Marketable securities

556

124

Accounts and notes receivable, net

8,308

6,005

Inventories

6,514

7,841

Prepaid expenses

296

279

Deferred income taxes

625

589

Total current assets

21,045

21,748

Property, plant and equipment, net of accumulated depreciation

   (June 30, 2015 - $20,256; December 31, 2014 - $19,942)

13,061

13,386

Goodwill

4,455

4,529

Other intangible assets

4,286

4,580

Investment in affiliates

895

886

Deferred income taxes

3,223

3,349

Other assets

1,141

1,058

Total

$

48,106

$

49,536





Liabilities and Equity



Current liabilities



Accounts payable

$

3,399

$

4,822

Short-term borrowings and capital lease obligations

647

1,423

Income taxes

613

547

Other accrued liabilities

4,046

5,848

Total current liabilities

8,705

12,640

Long-term borrowings and capital lease obligations

12,088

9,233

Other liabilities

13,188

13,819

Deferred income taxes

472

466

Total liabilities

34,453

36,158





Commitments and contingent liabilities








Stockholders' equity



Preferred stock

237

237

Common stock, $0.30 par value; 1,800,000,000 shares authorized;

   Issued at June 30, 2015 - 991,875,000; December 31, 2014 - 992,020,000

298

298

Additional paid-in capital

11,389

11,174

Reinvested earnings

17,838

17,045

Accumulated other comprehensive loss

(9,446)

(8,707)

Common stock held in treasury, at cost (87,041,000 shares at June 30, 2015 and

December 31, 2014)

(6,727)

(6,727)

Total DuPont stockholders' equity

13,589

13,320

Noncontrolling interests

64

58

Total equity

13,653

13,378

Total

$

48,106

$

49,536

 



E.I. du Pont de Nemours and Company
Condensed Consolidated Statement of Cash Flows
(Dollars in millions)


SCHEDULE A (continued)

Six Months Ended

June 30,

2015

2014

Total Company


Net income

$

1,980

$

2,519

Adjustments to reconcile net income to cash used for operating activities:


  Depreciation

615

635

  Amortization of intangible assets

257

245

  Net periodic pension benefit cost

294

205

  Contributions to pension plans

(204)

(168)

  Gain on sale of businesses

(22)

(398)

  Other operating activities - net

59

430

  Change in operating assets and liabilities - net

(5,024)

(5,539)

Cash used for operating activities

(2,045)

(2,071)




Investing activities


Purchases of property, plant and equipment

(938)

(781)

Investments in affiliates

(50)

(23)

Payments for businesses - net of cash acquired

(77)

—

Proceeds from sales of businesses - net

34

639

Proceeds from sales of assets - net

14

10

Net increase in short-term financial instruments

(422)

(22)

Foreign currency exchange contract settlements

443

(63)

Other investing activities - net

13

8

Cash used for investing activities

(983)

(232)




Financing activities


Dividends paid to stockholders

(875)

(836)

Net increase (decrease) in borrowings

2,110

(631)

Repurchase of common stock

(353)

(1,061)

Proceeds from exercise of stock options

201

214

Other financing activities - net

(81)

(76)

Cash provided by (used for) financing activities

1,002

(2,390)




Effect of exchange rate changes on cash

(138)

(74)




Decrease in cash and cash equivalents

(2,164)

(4,767)




Cash and cash equivalents at beginning of period

6,910

8,941




Cash and cash equivalents at end of period

$

4,746

$

4,174




Reconciliation of Non-GAAP Measure


Calculation of Free Cash Flow



Six Months Ended

June 30,

2015

2014

Cash used for operating activities

$

(2,045)

$

(2,071)

Purchases of property, plant and equipment

(938)

(781)

Free cash flow

$

(2,983)

$

(2,852)




(1) See Schedule B for detail of significant items.

(2) Year to date June 30, 2015 includes a $23 after-tax exchange loss on foreign pension balances.

 


E.I. du Pont de Nemours and Company
Schedule of Significant Items
(Dollars in millions, except per share amounts)











SCHEDULE B









SIGNIFICANT ITEMS


















Pre-tax

After-tax

($ Per Share)


2015

2014

2015

2014

2015

2014

1st Quarter










Separation transaction costs (1)

$

(81)

$

(16)

$

(80)

$

(12)

$

(0.09)

$

(0.01)

Customer claims recovery (4)

35

—

22

—

0.02

—

Asset impairment charge (5)

(37)

—

(30)

—

(0.03)

—

Ukraine devaluation (6)

(40)

—

(38)

—

(0.04)

—

1st Quarter - Total

$

(123)

$

(16)

$

(126)

$

(12)

$

(0.14)

$

(0.01)













2nd Quarter










Separation transaction costs (1)

$

(139)

$

(35)

$

(115)

$

(26)

$

(0.13)

$

(0.03)

Restructuring charges, net (2)

(61)

(263)

(42)

(182)

(0.04)

(0.20)

Litigation settlement (3)

112

—

72

—

0.08

—

Venezuela devaluation(7)

—

(58)

—

(57)

—

(0.06)

Gain on sale of business (8)

—

391

—

273

—

0.30

2nd Quarter - Total

$

(88)

$

35

$

(85)

$

8

$

(0.09)

$

0.01













Year-to-date Total(9)

$

(211)

$

19

$

(211)

$

(4)

$

(0.23)

$

—

E.I. du Pont de Nemours and Company
Schedule of Significant Items
(Dollars in millions, except per share amounts)

SCHEDULE B (continued)

(1)

Second quarter 2015 included charges of $(139) associated with transaction costs related to the separation of the Performance Chemicals segment consisting of $(119) recorded in other operating charges and $(20) recorded in interest expense. First quarter 2015 included charges of $(81) recorded in other operating charges associated with transaction costs related to the separation of the Performance Chemicals segment.

 

Second and first quarter 2014 included charges of $(35) and $(16), respectively, recorded in other operating charges associated with transaction costs related to the separation of the Performance Chemicals segment.

 


(2)

Second quarter 2015 included a $(61) restructuring charge recorded in employee separation/asset related charges, net consisting entirely of severance and related benefit costs in the Performance Chemicals segment to achieve fixed cost and operational productivity improvements for Chemours post-separation.

 

Second quarter 2015 included adjustments recorded in employee separation/asset related charges, net, associated with the 2014 restructuring program. These adjustments were primarily due to lower than estimated individual severance costs and workforce reductions achieved through non-severance programs, partially offset by identification of additional projects in certain segments. There was no impact of these adjustments to the company's interim Consolidated Income Statements. The net reduction impacted segment earnings for the three months ended as follows: Agriculture - $(4), Electronics & Communications - $11, Industrial Biosciences - $(1), Nutrition & Health - $(4), Performance Chemicals - $2, Performance Materials - $(2), Safety & Protection $1, and Other - $(3).

 

Second quarter 2014 included a $(263) restructuring charge recorded in employee separation/asset related charges, net, consisting of $(166) of severance and related benefit costs, $(94) of asset shut downs, and $(3) of other non-personnel charges as a result of the company's plan to reduce residual costs associated with the separation of the Performance Chemicals segment and to improve productivity across all businesses and functions.  Pre-tax charges by segment are: Agriculture - $(47), Electronics & Communications - $(68), Industrial Biosciences - $(2), Nutrition & Health - $(8), Performance Chemicals - $(19), Performance Materials - $(29), Safety & Protection - $(31), Other - $(2), and Corporate expenses - $(57).


(3)

Second quarter 2015 included a gain of $112, net of legal expenses, recorded in other income, net related to the company's settlement of a legal claim. This matter relates to the Safety & Protection segment.


(4)

The company recorded insurance recoveries of $35 in other operating charges, net, in the first quarter 2015, in the Agriculture segment, for recovery of costs for customer claims related to the use of the Imprelis® herbicide. The company had accruals of $216 related to these customer claims at June 30, 2015.


(5)

During first quarter of 2015, a $(37) pre-tax impairment charge was recorded in employee separation / asset related charges, net for a cost basis investment within the Other segment.  The assessment resulted from the venture's revised operating plan reflecting underperformance of its European wheat based ethanol facility and deteriorating European ethanol market conditions.  One of the primary investors has communicated they would not fund the revised operating plan of the investee.  As a result, the carrying value  of our 6% equity investment in this venture exceeds its fair value.

 


(6)

First quarter 2015 included a charge of $(40) in other income, net associated with remeasuring the company's Ukrainian hryvnia net monetary assets. Ukraine's central bank adopted a decision to no longer set the indicative hryvnia exchange rate. The hryvnia became a free-floating exchange rate and lost approximately a third of its value through the quarter.

 


(7)

Second quarter 2014 included a charge of $(58) recorded in other income, net associated with remeasuring the company's Venezuelan net monetary assets from the official exchange rate to the SICAD II exchange system.


(8)

Second quarter 2014 included a gain of $391 recorded in other income, net associated with the sale of Glass Laminating Solutions/Vinyls in the Performance Materials segment.


(9)

Earnings per share for the year may not equal the sum of quarterly earnings per share due to the changes in average share calculations.

 


E.I. du Pont de Nemours and Company
Consolidated Segment Information
(Dollars in millions)








SCHEDULE C







Three Months Ended

June 30,

Six Months Ended

June 30,

SEGMENT SALES (1)

2015

2014

2015

2014

Agriculture

$

3,218

$

3,615

$

7,155

$

8,009

Electronics & Communications

534

617

1,055

1,197

Industrial Biosciences

288

317

573

618

Nutrition & Health

826

926

1,639

1,787

Performance Chemicals

1,502

1,696

2,866

3,287

Performance Materials

1,365

1,582

2,776

3,116

Safety & Protection

925

1,029

1,834

1,976

Other

2

1

3

2

Total Segment sales

8,660

9,783

17,901

19,992








Elimination of transfers

(65)

(77)

(134)

(158)

Consolidated net sales

$

8,595

$

9,706

$

17,767

$

19,834








 


E.I. du Pont de Nemours and Company
Consolidated Segment Information
(Dollars in millions)









SCHEDULE C (continued)









Three Months Ended

June 30,

Six Months Ended

June 30,

INCOME BEFORE INCOME TAXES (GAAP)

2015

2014

2015

2014

Agriculture

$

774

$

789

$

1,948

$

2,231

Electronics & Communications

104

21

189

96

Industrial Biosciences

49

57

105

113

Nutrition & Health

99

97

188

190

Performance Chemicals

54

232

183

438

Performance Materials

309

665

636

958

Safety & Protection

308

178

492

353

Other

(60)

(84)

(163)

(176)

Total Segment PTOI

1,637

1,955

3,578

4,203

Corporate expenses

(283)

(278)

(528)

(495)

Interest expense

(127)

(94)

(211)

(197)

Non-operating pension/OPEB costs

(78)

(34)

(153)

(64)

Net exchange gains (losses)

26

(109)

90

(205)

Income before income taxes

$

1,175

$

1,440

$

2,776

$

3,242











Three Months Ended

June 30,

Six Months Ended

June 30,

SIGNIFICANT ITEMS BY SEGMENT (PRE-TAX) (2)

2015

2014

2015

2014

Agriculture

$

(4)

$

(47)

$

31

$

(47)

Electronics & Communications

11

(68)

11

(68)

Industrial Biosciences

(1)

(2)

(1)

(2)

Nutrition & Health

(4)

(8)

(4)

(8)

Performance Chemicals

(59)

(19)

(59)

(19)

Performance Materials

(2)

362

(2)

362

Safety & Protection

113

(31)

113

(31)

Other

(3)

(2)

(40)

(2)

Total significant items by segment

51

185

49

185

Corporate expenses

(119)

(92)

(200)

(108)

Interest expense

(20)

—

(20)

—

Net exchange gains (losses)

—

(58)

(40)

(58)

Total significant items before income taxes

$

(88)

$

35

$

(211)

$

19











Three Months Ended

June 30,

Six Months Ended

June 30,

OPERATING EARNINGS (NON-GAAP)

2015

2014

2015

2014

Agriculture

$

778

$

836

$

1,917

$

2,278

Electronics & Communications

93

89

178

164

Industrial Biosciences

50

59

106

115

Nutrition & Health

103

105

192

198

Performance Chemicals

113

251

242

457

Performance Materials

311

303

638

596

Safety & Protection

195

209

379

384

Other

(57)

(82)

(123)

(174)

Total segment operating earnings

1,586

1,770

3,529

4,018

Corporate expenses

(164)

(186)

(328)

(387)

Interest expense

(107)

(94)

(191)

(197)

Operating earnings before income taxes and exchange gains (losses)

1,315

1,490

3,010

3,434

Net exchange gains (losses) (3)

26

(51)

153

(147)

Operating earnings before income taxes

$

1,341

$

1,439

$

3,163

$

3,287














 

E.I. du Pont de Nemours and Company
Consolidated Segment Information
(Dollars in millions)











SCHEDULE C (continued)









Reconciliation of Segment Operating Earnings excluding the impact of currency (Non-GAAP)



Segment operating earnings excluding the impact of currency assumes current operating earnings results using foreign currency exchange rates in effect for the comparable prior-year period.

 








Three Months

Ended

June 30, 2014

Three Months Ended

June 30, 2015

 


Segment Operating

Earnings

Segment Operating Earnings

Impact of Currency

Segment Operating

Earnings Excluding

Currency

% Change

Agriculture

$

836

$

778

$

(84)

$

862

3%

Electronics & Communications

89

93

(3)

96

8

Industrial Biosciences

59

50

(6)

56

(5)

Nutrition & Health

105

103

(12)

115

10

Performance Chemicals

251

113

(43)

156

(38)

Performance Materials

303

311

(42)

353

17

Safety & Protection

209

195

(20)

215

3

Other

(82)

(57)

—

(57)

(30)

Total segment operating earnings

$

1,770

$

1,586

$

(210)

$

1,796

1%






















(1)  Segment sales include transfers.





(2)  See Schedule B for detail of significant items.





(3)  See Schedule D for additional information on exchange gains and losses.  Year to date June 30, 2015 exchange gains, on an operating earnings basis (Non-GAAP), excludes the impact of a $23 exchange loss on non-operating pension.











 



E.I. du Pont de Nemours and Company
Reconciliation of Non-GAAP Measures
(Dollars in millions, except per share amounts)










SCHEDULE D








Reconciliations of Adjusted EBIT / EBITDA to Consolidated Income Statements
















Three Months Ended

June 30,

Six Months Ended

June 30,



2015

2014

2015

2014

Income before income taxes

$

1,175

$

1,440

$

2,776

$

3,242

Add: Significant items benefit (charge) before income

taxes

88

(35)

211

(19)

Add: Non-operating pension/OPEB costs (1)

78

34

176

64

Operating earnings before income taxes

$

1,341

$

1,439

$

3,163

$

3,287

Less: Net income attributable to noncontrolling interests

5

4

9

10

Add:  Interest expense

107

94

191

197

Adjusted EBIT from operating earnings

1,443

1,529

3,345

3,474

Add: Depreciation and amortization

426

443

872

880

Adjusted EBITDA from operating earnings

$

1,869

$

1,972

$

4,217

$

4,354




















Reconciliation of Operating Earnings Per Share (EPS) Outlook



The reconciliation below represents the company's outlook on an operating earnings basis, defined as earnings excluding significant items and non-operating pension/OPEB costs.

















Year Ended December 31,







2015 Outlook (2)

2014 Actual (2)

Operating EPS (Non-GAAP)





$

3.10

$

3.36










Significant items








Separation transaction costs





(0.04)

(0.03)

Gain on sale of business





—

0.47

Restructuring charge, net





—

(0.40)

Venezuela devaluation





—

(0.06)

Tax items





—

—

Customer claims recovery





0.02

0.14

Litigation settlement





0.08

—

Asset impairment charge





(0.03)

—

Ukraine devaluation





(0.04)

—










Non-operating pension/OPEB costs - estimate





(0.28)

(0.09)










EPS (GAAP)





$

2.81

$

3.39










 

E.I. du Pont de Nemours and Company
Reconciliation of Non-GAAP Measures
(Dollars in millions, except per share amounts)









SCHEDULE D (continued)
















Exchange Gains/Losses on Operating Earnings(3)







The company routinely uses forward exchange contracts to offset its net exposures, by currency, related to the foreign currency denominated monetary assets and liabilities of its operations. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes. The net pre-tax exchange gains and losses are recorded in other income, net and the related tax impact is recorded in provision for (benefit from) income taxes on the Consolidated Income Statements.











Three Months Ended

June 30,

Six Months Ended

June 30,


2015

2014

2015

2014

Subsidiary Monetary Position Gain (Loss)







Pre-tax exchange gains (losses)

$

33

$

19

$

(87)

$

(31)

Local tax benefits (expenses)

28

(28)

(95)

(16)

Net after-tax impact from subsidiary exchange gains (losses)

$

61

$

(9)

$

(182)

$

(47)









Hedging Program Gain (Loss)







Pre-tax exchange (losses) gains

$

(7)

$

(70)

$

240

$

(116)

Tax benefits (expenses)

2

25

(87)

41

Net after-tax impact from hedging program exchange (losses) gains

$

(5)

$

(45)

$

153

$

(75)









Total Exchange Gain (Loss)







Pre-tax exchange gains (losses) (4)

$

26

$

(51)

$

153

$

(147)

Tax benefits (expenses)

30

(3)

(182)

25

Net after-tax exchange gains (losses)

$

56

$

(54)

$

(29)

$

(122)









As shown above, the "Total Exchange Gain (Loss)" is the sum of the "Subsidiary Monetary Position Gain (Loss)" and the "Hedging Program Gain (Loss)."









Reconciliation of Base Income Tax Rate to Effective Income Tax Rate



Base income tax rate is defined as the effective income tax rate less the effect of exchange gains (losses), as defined above, significant items and non-operating pension/OPEB costs.











Three Months Ended

June 30,

Six Months Ended

June 30,


2015

2014

2015

2014

Income before income taxes

$

1,175

$

1,440

$

2,776

$

3,242

Add:   Significant items - charge (benefit) (3)

88

(35)

211

(19)

           Non-operating pension/OPEB costs (1)

78

34

176

64

Less:  Net exchange gains (losses) (4)

26

(51)

153

(147)

Income before income taxes, significant items,






    exchange gains (losses), and non-operating pension/OPEB costs

$

1,315

$

1,490

$

3,010

$

3,434









Provision for income taxes

$

230

$

366

$

796

$

723

Add:  Tax benefits (expenses) on significant items

3

(27)

—

(23)

          Tax benefits on non-operating pension/OPEB costs

28

11

55

20

          Tax benefits (expenses) on exchange gains/losses

30

(3)

(182)

25

Provision for income taxes on operating earnings, excluding exchange gains

(losses)

$

291

$

347

$

669

$

745









Effective income tax rate

19.6%

25.4%

28.7%

22.3%

Significant items effect and non-operating pension/OPEB costs effect

(0.1)%

(1.1)%

(1.8)%

(0.4)%

Tax rate, before significant items and non-operating pension/OPEB costs

19.5%

24.3%

26.9%

21.9%

Exchange gains (losses) effect

2.6%

(1.0)%

(4.7)%

(0.2)%

Base income tax rate

22.1%

23.3%

22.2%

21.7%









 

E.I. du Pont de Nemours and Company
Reconciliation of Non-GAAP Measures
(Dollars in millions, except per share amounts)





SCHEDULE D (continued)








Reconciliation of Performance Chemicals Segment Pre-tax Operating Income (PTOI) (GAAP) to Operating Earnings and

Operating Earnings per Share (Non-GAAP)







Three Months Ended

June 30,

Performance Chemicals Segment

2015

2014

PTOI (GAAP)

$

54

$

232

Less: Segment significant items benefit (expense) (3)

(59)

(19)

Performance Chemicals Segment Operating Earnings (Non-GAAP)

$

113

$

251





Performance Chemicals Segment Operating Earnings - After-tax (Non-GAAP) (5)

88

193

Quarter-to-date weighted average diluted shares

912

926





Performance Chemicals Segment Operating Earnings per share - After-tax (Non-GAAP)

$

0.10

$

0.21





(1) Year to date June 30, 2015, non-operating pension/OPEB costs includes a $23 exchange loss on foreign pension balances.

(2) Restated on a continuing operations basis after Performance Chemicals has been reflected as a discontinued operation.

(3)  See Schedule B for detail of significant items.

(4) Year to date June 30, 2015 exchange gains, on an operating earnings basis (Non-GAAP), excludes a $23 exchange loss on non-operating pension.

(5) Performance Chemicals operating earnings assumes a base income tax rate from continuing operations of 22.1% and 23.3% for the three months ended June 30, 2015 and June 30, 2014, respectively.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/dupont-reports-2q-operating-eps-of-118-300119448.html

SOURCE DuPont

Copyright 2015 PR Newswire

DuPont de Nemours (NYSE:DD)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more DuPont de Nemours Charts.
DuPont de Nemours (NYSE:DD)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more DuPont de Nemours Charts.